Single-stage treatment of sternal wound complications in heart transplant recipients in whom pectoralis major myocutaneous advancement flaps were used  by Ascherman, Jeffrey A. et al.
SINGLE-STAGE TREATMENT 
OF STERNAL WOUND 
COMPLICATIONS IN HEART 
TRANSPLANT RECIPIENTS 
IN WHOM PECTORALIS 
MAJOR MYOCUTANEOUS 
ADVANCEMENT FLAPS 
WERE USED 
Treatment of sternal wound complications is controversial, particularly in 
immunosuppressed heart transplant recipients. Regardless of the severity 
of infection, we combine immediate, aggressive d~bridement with bilateral 
pectoralis major myocutaneous advancement flaps in a single procedure. 
Compared with management with pectoralis major turnover flaps or 
distant pedicled muscle flaps, treatment of these sternal wounds with 
pectoralis major myocutaneous advancement flaps is simpler and quicker 
and provides better aesthetic results. Furthermore, because pectoralis 
major myocutaneous flaps are based on the thoracoacromial arteries, 
whether or not the internal mammary arteries have previously been 
harvested for coronary grafts is irrelevant. Twenty consecutive heart 
transplant recipients with sternal wound complications were treated with 
this technique. No intraoperative or perioperative deaths occurred. The 
morbidity rate was 30%, with seroma treated by needle aspiration in four 
patients (20%) being the most common complication. Only one patient had 
a postoperative wound infection. All patients had excellent functional and 
aesthetic results. (J THORAC CARDIOVASC SURG 1995;110:1030-6) 
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S ternal wound complications after median ster- notomy are a significant problem, particularly in 
immunosuppressed heart transplant recipients. Re- 
ported mediastinal and sternal infection rates after 
cardiac surgery range from 0.4% to 5.1%? -7 Unilat- 
eral or bilateral internal mammary artery grafts, 
diabetes, and immunosuppression may all predis- 
pose a patient to these infections. 5'8 Subsequent 
sepsis or infectious spread to prosthetic valves, 
grafts, or suture lines, can be life-threatening. 
A variety of early treatments have been proposed 
for sternal wound infections, including delayed clo- 
sure, closed catheter irrigation, 9 and omental flaps 
to the mediastinum. 1° D6bridement followed by 
closure with muscle or myocutaneous flaps has been 
advocated more recently. 11-24 The pectoralis major, 
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rectus abdominis, and latissimus dorsi muscles have 
all been used for this purpose. The pectoralis major 
is used most commonly. Sometimes it is isolated on 
internal mammary artery perforators and used as a 
turnover flap. 4' 22 Others use it as an advancement 
flap based on the thoracoacromial rtery, z° By a 
separate lateral incision, the muscle may be divided 
from its humeral attachment to aid advancement. A 
rectus abdominis muscle flap may be included to 
cover the inferior segment of the wound. 4
We treat sternal wound complications with ag- 
gressive d6bridement and simultaneous closure us- 
ing bilateral pectoralis major myocutaneous (PMM) 
advancement flaps. In this report, we describe our 
experience with this single-stage procedure in heart 
transplant recipients. 
Patients and methods 
Twenty consecutive sternal wound complications in 
heart transplant recipients were managed with PMM 
advancement flaps at the Columbia-Presbyterian Medical 
Center between January 1986 and June 1992. This repre- 
sents 4.2% of the 477 heart transplantations (459 first- 
time transplantations, 18 repeated transplantations) per- 
formed at our institution during this period. Indications 
for treatment with PMM advancement flaps are listed in 
Table I. Culture-positive deep wound infections (13/20, 
65%) were the most common indication for treatment. 
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Table I. Indications for operation 
Preoperative condition No. % 
Deep wound infection, cultures positive 13 65 
Prolonged sternal drainage, cultures nega- 1 5 
tive 
Sternal dehiscence, cultures negative 1 5 
Sternal dehiscence and prolonged drainage, 2 10 
cultures negative 
Delayed sternal closure 3 15 
20 100 
Table II. Microbiology of  culture-positive wound 
infections 
Organism No. % 
Staphylococcus aureus 7 53.8 
S. aureus and Streptococcus group D 1 7.7 
Anaerobic streptococci 1 7.7 
Escherichia coli 1 7.7 
Acinetobacter 1 7.7 
Serratia 1 7.7 
Serratia nd Klebsiella 1 7.7 
13 100 
Several patients (4/20, 20%) had a culture-negative d his- 
cence or culture-negative drainage, but clinically their 
courses were consistent with sternal wound infection. 
Combining these 4 with the 13 culture-positive infections, 
our institution's overall sternal wound infection rate after 
heart transplantation was 3.6%. The remaining 3 patients 
(15%) did not have wound infections but underwent the 
procedure to obtain a delayed primary closure of their 
median sternotomy wound. Definitive closure at the time 
of transplantation had been precluded by hemodynamic 
instability. After stability was achieved, these patients 
returned to the operating room for closure with PMM 
advancement flaps rather than with sternal wiring, 
Of the 13 culture-positive wound infections, more than 
half involved Staphylococcus aureus (Table II). Seven 
(7/13, 54%) of the infections were caused by this organism 
alone, and another (1/13, 8%) involved Staphylococcus 
aureus and Streptococcus group D. 
In the 17 patients with documented or suspected sternal 
wound infections (13 with cultures positive for bacteria, 4
with a culture-negative dehiscence or culture-negative 
drainage), the median number of days between heart 
transplantation a d reoperation for PMM flap closure was 
17, with a range of 4 days to 4 months. More specifically, 
among these 17 patients the time from transplantation to
flap closure (Table iii) was 1 week or less in 3 patients 
(18%), between 1 and 4 weeks in 9 patients (53%), and 
more than 4 weeks in 5 patients (29%). 
All 20 patients underwent reatment with PMM ad- 
vancement flaps. In patients with evidence of a deep 
sternal wound infection, we operate immediately. The 
procedure is begun by fully reopening the original median 
sternotomy incision. All sternal wires are removed. In 
patients with suspected or culture-proven i fections, the 
sternum is d6brided back to bleeding bone. Mediastinal 
fluid and sternal bone are cultured. 
PMM flaps are raised from medial to lateral in the 
relatively avascular plane beneath the pectoralis major 
muscles. This dissection is rapid and relatively bloodless. 
Superiorly, the dissection is stopped at the level of the 
clavicles. Laterally, the PMM flaps are raised as far as the 
anterior axillary line. The humeral insertion of the pecto- 
ralis major, the thoracoacromial vessels, and the pectoral 
nerves are all left intact. The pectoralis minor muscle is 
also left undisturbed. Inferiorly, the dissection passes 
below the superior fibers of the anterior ectus sheath but 
stays superficial to the actual rectus abdominis muscle 
(Figs. 1 and 2). 
After these myocutaneous flaps have been raised bilat- 
Table I I I .  Operative timing of  17 infected 
sternotomy wounds 
Time from heart ransplantation 
to flap closure No. of patients 
-<7 days 3 
8-28 days 9 
->29 days 5 
17 
erally, the wound is flushed with 3 L of antibiotic solution 
with a pulse irrigator. A closed suction drain is placed 
under each flap, and a third drain is inserted in the 
mediastinum. 
The flaps are then easily advanced to the midline. Al- 
though the underlying sternum is not rewired, there is 
minimal, if any, residual dead space. A strong, absorbable 
suture is used to appose the pectoralis major muscles and 
their overlying fascia. Inferiorly, the superior portion of the 
anterior ectus sheath is included in this deep layer of the 
closure. Skin is closed with either a running nylon suture or 
two layers of absorbable sutures (Fig. 3). Culture results 
determine the choice and duration of antibiotic therapy. 
Survival analysis in this study was performed by the 
Kaplan-Meier product-limit estimate. Statistical signifi- 
cance between curves was examined with a log-rank 
test, with significance defined as a p value of less than 
0.05. 
Results 
Our average operative time for the procedure was 
2 hours. The average estimated blood loss was 
550 ml. Patients were usually extubated in the 
operating room, and postoperative admission to 
the intensive care unit was not always necessary. The 
mean number of postoperative days until the last 
drain was removed was 11, with a range of 3 to 21 
days. Median length of hospitalization after flap 
closure was 28 days, with a range of 14 days to 10 
months. (One patient's stay was prolonged to 10 
months for reasons unrelated to the sternal wound 
infection.) The functional and aesthetic results of  
the procedure have been excellent. ShoUlder mobil- 
ity has not been affected by the operation. Chest 
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Rectus abdominis muscle 
Rectus abdominis sheath 
Pectoralis major muscle 
Fig. 1. Elevation of myocutaneous flap in plane deep to p ctoralis major muscle. Notice elevation of 
anterior rectus sheath, but not rectus abdominis muscle, in caudad portion of wound. 
Fig. 2. Intraoperative view of elevated PMM flap. 
wall contour is similar to that of patients who 
undergo uncomplicated median sternotomies (Fig. 
4). With an average follow-up of 31/2 years and a 
maximum follow-up of 7 years, there have been no 
complaints of prolonged pain or of chest wall or 
sternal instability. 
There were no deaths in the intraoperative p riod 
or within 30 days after operation in our series. Six 
patients (30%) experienced postoperative morbidity 
(Table IV). The most common untoward sequela 
was seroma formation, which occurred in 4 (20%) 
patients. Each occurred after all drains had been 
removed and was managed by simple needle aspira- 
tion, either at the bedside or during outpatient visits. 
Two patients had partial wound dehiscences, both 
of which were closed under sterile technique at the 
bedside. There were no complete dehiscences. One 
patient was taken back to the operating room from 
the recovery room to rule out a hematoma; marked 
muscle edema, rather than hematoma, was found. 
Another patient had a delayed hemorrhage, which 
was treated with bedside aspiration on postoperative 
day 32. 
Only one patient had a postoperative wound 
infection. This patient did well initially and was 
discharged to his home 25 days after his PMM flap 
procedure. Because of continued serous wound 
drainage, however, he had a computed tomography 
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Drains 
Fig. 3. Cross-sectional view of closure over drains. 
Fig. 4. Normal chest contour in patient 6 weeks after treatment with PMM flaps. 
chest scan 4t/2 months after his flap procedure. This 
revealed a subpectoral collection that necessitated 
readmission. In the operating room, an abscess was 
drained, the surrounding necrotic ssue was d6- 
brided, and the PMM flaps were reapproximated. 
The patient subsequently did well and has had no 
evidence of recurrent infection for 2 years. 
Examination of the Kaplan-Meier curves shows 
no statistically significant difference (p = 0.32) in 
survival between the 17 patients in this series with 
sternal wound infections and the 442 patients who 
received initial heart transplants at our institution 
during this same period and did not have sternal 
wound infections (Fig. 5). 
Discussion 
Median sternotomy has become the preferred 
incision for open cardiac procedures ince its de- 
Table IV. Morbidity 
No. treated No. treated 
Diagnosis at bedside in operating room Total 
Seroma 4 - -  4 
Partial dehiscence 2 - -  2 
Hematoma 1 - -  1 
Rule out hematoma - -  1 1 
Subpectoral  abscess 1 1 
*Total number of patients = 6. (Several patients had more than one type 
of morbidity.) 
scription by Julian and colleagues 25in 1957. Com- 
plications associated with median sternotomy, such 
as infection, can be disastrous. Our institution's 
overall infection rate for median sternotomies i
1.3%, 23 well within the rates of 0.4% to 5.1% 
published in other seriesJ -7 Not surprisingly, our 
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Fig. 5. Kaplan-Meier estimates for heart ransplant recipients with sternal wound infections treated with 
PMM flaps and for all other patients undergoing an initial heart transplant during the same period at 
Columbia-Presbyterian Medical Center (January 1986 to June 1992; n = 459). 
sternal wound infection rate in immunosuppressed 
heart transplant recipients is higher--3.6%. This is 
comparable with the rate of 4.5% published by 
Hofflin and colleagues 26 in a series of 110 heart 
transplant recipients. When sternal infections do 
arise, particularly in heart transplant recipients, a
rapid, effective treatment is required to avoid poten- 
tially life-threatening sequelae. 
Some surgeons have advocated 6bridement and 
frequent packing changes, sometimes followed by a 
delayed closure, for these infections. However, this 
treatment may involve prolonged hospitalization. 
Furthermore, wound healing times of up to 16 
months 27 and mortality rates as high as 46% 28 have 
been recorded with this treatment. 
In 1963, operative d6bridement followed by ster- 
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nal closure over irrigation catheters was reported. 9 
This approach did shorten average hospitalization 
times, 7but reoperation rates for persistent infection 
ranged from 13% to 66%. 29. 30 Fatal superinfection 
and systemic toxicity caused by the irrigation solu- 
tion were other problems reported with this treat- 
ment. 29 
Many surgeons now transpose vascularized tissue 
into these relatively avascular wounds. In 1976, Lee, 
Schimert, and Shatkin 1° described the use of the 
greater omentum for this procedure in 3 patients. 
However, use of the omentum required an addi- 
tional laparotomy. Other flaps have been advocated 
for treatment of sternal wound infections ince then, 
including the rectus abdominis and pectoralis major 
flaps. 4'a1-24 The effectiveness of muscle flaps in 
treating osteomyelitis has been demonstrated in 
studies by Mathes, Alpert, and Chang. 31 Use of the 
rectus abdominis flap entails a significant increase in 
the amount of dissection required and is sometimes 
followed by abdominal hernia formation. Even more 
important, this flap may be unavailable if the inter- 
nal mammary arteries were either used for coronary 
artery bypass grafting or damaged by sternal wires. 
The most frequently used flap today for treating 
sternal wound infections is the pectoralis major flap. 
Some surgeons use it as a turnover flap based on its 
medial blood supply. 22 However, this involves divid- 
ing the pectoralis major laterally and rotating the 
lateral portion of the muscle into the wound, a 
technique that leaves additional contour deformities 
and may require separate counterincisions. Further- 
more, like the rectus abdominis flap, this turnover 
flap requires a patent internal mammary artery. It is 
therefore not an option in many patients. 
In contrast to the aforementioned techniques, use 
of PMM advancement flaps does not require intact 
internal mammary arteries, involves no additional 
incisions, leaves no functional deficits, and produces 
excellent cosmetic results. We have also found sim- 
ple advancement of the anterior ectus sheath to the 
midline to provide sufficient coverage inferiorly. 
Although some believe that our method does not 
adequately "fill" the mediastinal dead space, we 
have not found this to be a problem. The only 
recurrent infection in our series was a subpectoral 
collection detected 41/2 months after operation. In 
addition, as demonstrated byKaplan-Meier survival 
analysis, heart transplant recipients treated for ster- 
nal wound infections with this technique have shown 
no decrease in long-term survival compared with 
patients without these infections. 
We recommend this single-stage approach for the 
treatment of sternal wound complications in heart 
transplant recipients. In a separate study, we 23 also 
found this method extremely efficacious for manage- 
ment of sternal wound complications in patients not 
undergoing transplantation. We emphasize arly, 
aggressive d6bridement of all necrotic bone and 
immediate coverage with PMM advancement flaps. 
This method is simple and effective and produces 
excellent functional and cosmetic results. The asso- 
ciated morbidity has been low, particularly consid- 
ering how ill these immunocompromised patients 
are. Furthermore, in contrast o the rectus abdomi- 
nis and pectoralis turnover flaps, PMM advance- 
ment flaps do not require intact internal mammary 
arteries. 
We thank Alan Weinberg, MS, and Michael Sternberg, 
BS, for their help with the statistical analysis of our 
data. 
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